Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. FDA accelerated review denial is a blow to Spectrum’s poziotinib
  2. New drugs and therapeutic options help the immune system fight cancer
  3. Roche’s Tecentriq threatens BMS’ Opdivo in small cell lung cancer market
  4. The challenges of using stem cells in neurology
  5. Another BACE inhibitor fails in phase III trials

Latest Content

January’s top news stories

Janssen Pharmaceutical Companies of Johnson & Johnson unblinded the Phase III TITAN trial investigating Erleada (apalutamide) in combination with androgen deprivation therapy (ADT) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).

Customised R&D Services

AntalGenics offers the technology and knowledge required for the management of a wide variety of active ingredient formulation. Its research and development (R&D) capabilities provide high-quality design and development activities to meet the client's requirements.

Eligen® Technology Mechanism of Action

Emisphere's Eligen® Technology binds a delivery agent with a therapeutic compound without alternation. This process occurs when both agent and compound are in close proximity.

B&W Tek NanoRam Handheld Raman Spectrometer

The NanoRam is a state-of-the-art handheld Ramen instrument for non-destructive identification and verification of incoming raw materials such as active pharmaceutical ingredients (API), excipients, and intermediates.

B&W Tek

This video is about the services that B&W Tek offers.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top